References
1. Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong
PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work
group. KDIGO 2012 clinical practice guideline for the evaluation and
management of chronic kidney disease, Kidney International Supplements.
2013;3(1):1–150.
2. Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al.
Global kidney health 2017 and beyond: a roadmap for closing gaps in
care, research, and policy. Lancet. 2017;390(10105):1888-1917.
3. Webster AC, Nagler E V., Morton RL, Masson P. Chronic Kidney Disease.
Lancet.2017; 389(10075):1238-1252
4. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al.
Global, regional, and national burden of chronic kidney disease,
1990–2017: a systematic analysis for the Global Burden of Disease Study
2017. Lancet. 2020;395(10225):709–733.
5. Atamari-Anahui N, Ccorahua-Rios MS, Condori-Huaraka M,
Huamanvilca-Yepez Y, Amaya E, Herrera-Añazco P. Epidemiology of chronic
kidney disease in Peru and its relation to social determinants of
health. Int Health. 2020;12(4):264–271.
6. Fei Y, Wang X, Zhang H, Huang M, Chen X, Zhang C. Reference intervals
of systemic immune-inflammation index, neutrophil to lymphocyte ratio,
platelet to lymphocyte ratio, mean platelet volume to platelet ratio,
mean platelet volume and red blood cell distribution width-standard
deviation in healthy Han adults in Wuhan region in central China. Scand
J Clin Lab Invest. 2020;80(6):1–8.
7. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The
platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic
diseases. Ann Lab Med. 2019;39(4):345-357.
8. Kurtul A, Ornek E. Platelet to Lymphocyte Ratio in Cardiovascular
Diseases: A Systematic Review. Angiology. 2019; 70(9):802-818.
9. Kotani K, Sakane N. White blood cells, neutrophils, and reactive
oxygen 4metabolites among asymptomatic subjects. Int J Prev Med.
2012;3(6):428–431.
10. Nicolai L, Schiefelbein K, Lipsky S, Leunig A, Hoffknecht M,
Pekayvaz K, et al. Vascular surveillance by haptotactic blood platelets
in inflammation and infection. Nat Commun. 2020;11(1):5778.
11. Saito R, Shoda K, Maruyama S, Yamamoto A, Takiguchi K, Furuya S, et
al. Platelets enhance malignant behaviours of gastric cancer cells via
direct contacts. Br J Cancer. 2020; doi: 10.1038/s41416-020-01134-7.
12. Portier I, Campbell RA. Role of Platelets in Detection and
Regulation of Infection. Arterioscler Thromb Vasc Biol.
2020;ATVBAHA120314645.
13. Warren E, Teskey G, Venketaraman V. Effector Mechanisms of
Neutrophils within the Innate Immune System in Response to Mycobacterium
tuberculosis Infection. J Clin Med. 2017;6(2):15.
14. Valga F, Monzón T, Henriquez F, Antón-Pérez G.
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as biological
markers of interest in kidney disease. Nefrología. 2019;39(3):243–249.
15. Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Katafuchi E, Seki M, et
al. High neutrophil/lymphocyte ratio is associated with poor renal
outcomes in Japanese patients with chronic kidney disease. Ren Fail.
2019;41(1):238–243.
16. Seropian IM, Romeo FJ, Pizarro R, Vulcano NO, Posatini RA,
Marenchino RG, et al. Neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio as predictors of survival after heart
transplantation. ESC Hear Fail. 2018;5(1):149–156.
17. Zheng J, Cai J, Li H, Zeng K, He L, Fu H, et al. Neutrophil to
Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic
Predictors for Hepatocellular Carcinoma Patients with Various
Treatments: A Meta-Analysis and Systematic Review. Cell Physiol Biochem.
2017;44(3):967–981.
18. Aydin O, Pehlivanll F. Is the Platelet to Lymphocyte Ratio a
Potential Biomarker for Predicting Mortality in Peptic Ulcer
Perforation? Surg Infect (Larchmt). 2019;20(4):326–331.
19. Sevencan NO, Ozkan AE. Associations between neutrophil/lymphocyte
ratio, platelet/lymphocyte ratio, albuminuria and uric acid and the
estimated glomerular filtration rate in hypertensive patients with
chronic kidney disease stages 1–3. Arch Med Sci. 2019;15(5):1232–1239.
20. Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, et al.
Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in
Chinese patients with chronic kidney disease: Results from the Chinese
Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med. 2019
Mar 15;17(1);86.
21. Tatar E, Mirili C, Isikyakar T, Yaprak M, Guvercin G, Ozay E, et al.
The association of neutrophil/lymphocyte ratio and platelet/lymphocyte
ratio with clinical outcomes in geriatric patients with stage 3–5
chronic kidney disease. Acta Clin Belgica Int J Clin Lab Med.
2016;71(4):221–226.
22. Catabay C, Obi Y, Streja E, Soohoo M, Park C, Rhee CM, et al.
Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis
Patients. Am J Nephrol. 2017;46(5):408–416.
23. Lu X, Wang S, Zhang G, Xiong R, Li H. High neutrophil-to-lymphocyte
ratio is a significant predictor of cardiovascular and all-cause
mortality in patients undergoing peritoneal dialysis. Kidney Blood Press
Res. 2018;43(2):490–499.
24. Sato H, Takeuchi Y, Matsuda K, Kagaya S, Saito A, Fukami H, et al.
Pre-Dialysis Neutrophil-Lymphocyte Ratio, a Novel and Strong Short-Term
Predictor of All-Cause Mortality in Patients With Diabetic Nephropathy:
Results From a Single-Center Study. Ther Apher Dial.
2017;21(4):370–377.
25. Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B.
Mortality in chronic kidney disease and renal replacement therapy: A
population-based cohort study. BMJ Open. 2014;4(2).
26. Peterson K, Anderson J, Boundy E, Ferguson L, McCleery E, Waldrip K.
Mortality disparities in racial/ethnic minority groups in the veterans
health administration: An evidence review and Map. Am J Public Health.
2018;108(3):e1-e11.
27. Desai N, Lora CM, Lash JP, Ricardo AC. CKD and ESRD in US Hispanics.
Am J Kidney Dis. 2019;73(1):102-111.
28. Branch M, German C, Bertoni A, Yeboah J. Incremental risk of
cardiovascular disease and/or chronic kidney disease for future ASCVD
and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J
Diabetes Complications. 2019;33(7):468–472.
29. Moranne O, Fafin C, Roche S, Francois M, Allot V, Potier J, et al.
Treatment plans and outcomes in elderly patients reaching advanced
chronic kidney disease. Nephrol Dial Transplant. 2018;33(12):2182–2191.
30. Imig JD, Ryan MJ. Immune and inflammatory role in renal disease.
Compr Physiol. 2013;3(2):957–976.
31. Okyay GU, Inal S, Öneç K, Er RE, Paşaoǧlu Ö, Paşaoǧlu H, et al.
Neutrophil to lymphocyte ratio in evaluation of inflammation in patients
with chronic kidney disease. Ren Fail. 2013;35(1):29–36.
32. Toraman A, Neşe N, Özyurt B, Kürşat S. Association between
neutrophil-lymphocyte & platelet lymphocyte ratios with prognosis &
mortality in rapidly progressive glomerulonephritis. Indian J Med Res.
2019;150(4):399–406.
33. Zeng M, Liu Y, Liu F, Peng Y, Sun L, Xiao L. J-shaped association of
platelet-to-lymphocyte ratio with 5-year mortality among patients with
chronic kidney disease in a prospective cohort study. Int Urol Nephrol.
2020;52(10):1943–1957.
34. Cognasse F, Laradi S, Berthelot P, Bourlet T, Marotte H, Mismetti P,
et al. Platelet inflammatory response to stress. Front Immunol.
2019;10(JUN):1478.
35. Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H,
et al. Association of epicardial adipose tissue,
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with
diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794–180